Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison

BACKGROUND: About one third of patients infected with human immunodeficiency virus (HIV) also have chronic hepatitis due to hepatitis C virus (HCV). HCV therapy with simeprevir, pegylated interferon alfa (PegIFNα) and ribavirin (RBV) have been shown to be superior to PegIFNα + RBV alone in non-HIV p...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersohn, Frank, Claes, Anne-Kathrin, Kulp, Werner, Mahlich, Jörg, Rockstroh, Jürgen Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709957/
https://www.ncbi.nlm.nih.gov/pubmed/26753774
http://dx.doi.org/10.1186/s12879-015-1311-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709957/
https://www.ncbi.nlm.nih.gov/pubmed/26753774
http://dx.doi.org/10.1186/s12879-015-1311-3

Ejemplares similares